USPH U.S. Physical Therapy Company Future Sales Volume

Public company logo of U.S. Physical Therapy (USPH)

The partnership model of U.S. Physical Therapy (USPH) and inelastic demand support the share price, while the organization's planned trading revenue demonstrates expansion potential. However, labor shortages and price regulation exert pressure on margins, although the geopolitical backdrop remains stable. The current value of the indicator is 0.84, providing a quantitative signal regarding the scale of business development within a protected local environment.

usph.com - USPH Company Future Revenue (period 07/04/2022 - 11/15/2026)

Financial and market metric breakdowns for U.S. Physical Therapy, Inc. (USPH)

- stock value and consensus price forecast:
Analysis of all company metrics:USPH usph.com
Brand item of usph.com

For U.S. Physical Therapy (USPH), which operates within the isolated and stable environment of U.S. healthcare, assessing future sales volume serves as a tool for identifying hidden deviations from the long-term development vector. This metric analyzes historical revenue cycles, where an anomalous gap between the trend and the forecast signals internal operational risks or management inefficiency in overseeing the local clinic network to the investor.

Main competitors

Company Future Sales Volume HCA (HCA Inc.)|THC - Company Expected Sales Volume|Projected Sales Volume FMS (freseniusmedicalcare.com)|Solventum Inc. - Company Projected Revenue|EHC - Company Projected Revenue|Company Future Revenue UHS (Universal Health Services, Inc.)|DVA (DaVita) - Company Future Sales Volume|RDNT: Company Projected Revenue Volume|Company Future Sales Volume OPCH|Company Expected Sales Volume Surgery Partners, Inc. SGRY|Company Future Sales Volume PINC (Premier, Inc.)|EYE (National Vision) - Company Future Revenue|Projected Sales Volume PGNY (Progyny Inc)|Ardent Health Partners (ARDT) - Company Expected Sales Volume|Select Medical Inc. - Projected Sales Volume|Company Expected Sales Volume Apollo Medical Holdings|MD: Projected Sales Volume|PNTG: Company Projected Revenue Volume|ORGO (Organogenesis Holdings Inc.) - Projected Sales Volume|NUTX: Company Future Revenue|Company Projected Revenue Auna Health (AUNA)|SBC (SBC Medical Group Holdings) - Company Future Revenue|Company Projected Revenue Evolus, Inc. EOLS|Company Projected Revenue Volume CYH (Community Health Systems)|SKIN - Company Projected Revenue|mediwound.com (MDWD) - Company Future Sales Volume|BTMD (biote Corp) - Company Future Sales Volume|JYNT: Company Projected Revenue Volume|DCGO (DocGo, Inc.) - Projected Sales Volume|Company Projected Revenue PIII|Company Future Sales Volume GANX (Gain Therapeutics, Inc.)|EUDA - Company Expected Sales Volume|Company Projected Revenue Basel Medical BMGL|CollPlant Biotechnologies (CLGN) - Company Expected Sales Volume|CUPR: Company Future Sales Volume|Company Future Sales Concord Medical Services CCM|AMS (American Shared Hospital) - Company Future Sales Volume|Company Revenue Forecast MRM|Company Projected Revenue avalon-globocare.com|Projected Sales Volume DIH Holding US Inc.|Company Projected Revenue Carmell Therapeutics (XAGE)|newgenivf.com - Company Revenue Forecast|Company Projected Revenue ATI Physical Therapy Inc. ATIP|CMAX: Company Revenue Forecast|kindlymd.com - Projected Sales Volume|Company Expected Sales Volume ModivCare Corp|NVOS (Novo Integrated Sciences) - Company Future Sales Volume|SunLink Health Systems Inc. - Company Future Revenue|Company Future Sales Volume BACK